Oct 4, 2016 Cellectar Biosciences Announces USPTO Issues Formal Patent Allowance for CLR 1603 Learn More
Sep 29, 2016 Cellectar Biosciences Announces New Positive Data from Phase I Clinical Study of CLR 131 in Multiple Myeloma Learn More
Sep 19, 2016 Cellectar Biosciences to Present at Ladenburg Thalmann 2016 Healthcare Conference Learn More